165 related articles for article (PubMed ID: 37103562)
1. Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal Therapy.
Magee DE; Cheung DC; Hird AE; Chung P; Warde P; Catton C; Berlin A; Zlotta A; Fleshner NE; Kulkarni GS
Urol Pract; 2023 Jul; 10(4):293-299. PubMed ID: 37103562
[TBL] [Abstract][Full Text] [Related]
2. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Ray-Zack MD; Hudgins HK; Jazzar U; Tyler DS; Freedland SJ; Swanson TA; Baillargeon JG; Hu JC; Kaul S; Kamat AM; Gore JL; Mehta HB
JAMA Surg; 2019 Aug; 154(8):e191629. PubMed ID: 31166593
[TBL] [Abstract][Full Text] [Related]
4. Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer.
Golla V; Shan Y; Farran EJ; Stewart CA; Vu K; Yu A; Khaki AR; Parikh DA; Swanson TA; Keegan KA; Kamat AM; Tyler DS; Freedland SJ; Williams SB
Urol Oncol; 2022 Jun; 40(6):273.e1-273.e9. PubMed ID: 35168881
[TBL] [Abstract][Full Text] [Related]
5. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
[TBL] [Abstract][Full Text] [Related]
6. Trimodal therapy for muscle-invasive bladder cancer.
Mathes J; Rausch S; Todenhöfer T; Stenzl A
Expert Rev Anticancer Ther; 2018 Dec; 18(12):1219-1229. PubMed ID: 30324833
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
[TBL] [Abstract][Full Text] [Related]
8. Bladder sparing surgery in high-grade bladder cancer.
Yakovlev PG; Klyushin DA; Vereshchako RI
Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
[TBL] [Abstract][Full Text] [Related]
9. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
[TBL] [Abstract][Full Text] [Related]
10. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.
Chahal R; Sundaram SK; Iddenden R; Forman DF; Weston PM; Harrison SC
Eur Urol; 2003 Mar; 43(3):246-57. PubMed ID: 12600427
[TBL] [Abstract][Full Text] [Related]
11. Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed With Localized Muscle-Invasive Bladder Cancer: Understanding the Value of Surgical Care.
Bagheri I; Shan Y; Klaassen Z; Kamat AM; Konety B; Mehta HB; Baillargeon JG; Srinivas S; Tyler DS; Swanson TA; Kaul S; Hollenbeck BK; Williams SB
Urology; 2021 Jan; 147():127-134. PubMed ID: 32980405
[TBL] [Abstract][Full Text] [Related]
12. [Bladder-sparing trimodal therapy for muscle invasive bladder cancer].
Khalifa J; Roumiguié M; Pouessel D; Sargos P
Cancer Radiother; 2022 Oct; 26(6-7):771-778. PubMed ID: 35970682
[TBL] [Abstract][Full Text] [Related]
13. Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer.
Feldman AS; Kulkarni GS; Bivalacqua TJ; Black PC; Delacroix S; Lerner SP; Kamat AM; Kassouf W
Urol Oncol; 2022 Oct; 40(10):442-450. PubMed ID: 33642229
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of trimodal chemoradiotherapy with gemcitabine and cisplatin as a bladder-preserving strategy for the treatment of muscle-invasive bladder cancer: a single-arm phase II study.
Kobayashi K; Matsumoto H; Misumi T; Ito H; Hirata H; Nagao K; Matsuyama H
Jpn J Clin Oncol; 2022 Oct; 52(10):1201-1207. PubMed ID: 35675636
[TBL] [Abstract][Full Text] [Related]
15. Trimodal therapy in muscle invasive bladder cancer management.
Polo-Alonso E; Kuk C; Guruli G; Paul AK; Thalmann G; Kamat A; Solsona E; Thalmann G; Urdaneta AI; Zlotta AR; Mir MC
Minerva Urol Nefrol; 2020 Dec; 72(6):650-662. PubMed ID: 33263367
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions?
Wettstein MS; Rooprai JK; Pazhepurackel C; Wallis CJD; Klaassen Z; Uleryk EM; Hermanns T; Fleshner NE; Zlotta AR; Kulkarni GS
PLoS One; 2019; 14(4):e0216255. PubMed ID: 31034504
[TBL] [Abstract][Full Text] [Related]
17. Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy?
Mathieu R; Lucca I; Klatte T; Babjuk M; Shariat SF
Curr Opin Urol; 2015 Sep; 25(5):476-82. PubMed ID: 26125510
[TBL] [Abstract][Full Text] [Related]
18. [Trimodal, organ-preserving treatment of organ-confined, muscle-invasive bladder cancer].
Ágoston P; Jorgo K; Kocsis ZS; Varga L; Gesztesi L; Takácsi-Nagy Z; Polgár C
Magy Onkol; 2021 Dec; 65(4):319-328. PubMed ID: 34874363
[TBL] [Abstract][Full Text] [Related]
19. Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer.
Eswara JR; Efstathiou JA; Heney NM; Paly J; Kaufman DS; McDougal WS; McGovern F; Shipley WU
J Urol; 2012 Feb; 187(2):463-8. PubMed ID: 22177159
[TBL] [Abstract][Full Text] [Related]
20. Is trimodal therapy the current standard for muscle-invasive bladder cancer?
López Valcárcel M; Barrado Los Arcos M; Ferri Molina M; Cienfuegos Belmonte I; Duque Santana V; Gajate Borau P; Fernández Ibiza J; Álvarez Maestro M; Sargos P; López Campos F; Couñago F
Actas Urol Esp (Engl Ed); 2024 Jun; 48(5):345-355. PubMed ID: 38575067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
